Interval debulking in epithelial ovarian carcinomas: The past, present and the future

European Journal of Gynaecological Oncology

Volumn 29, Issue 3, 2008, Pages 242-245

  Gultekin, M ^a,d   Diribas, K ^a   Buru, E ^a   Dursun, P ^b   Yuce, K ^c   Ayhan, A ^b  

^a Cankiri Government Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Cankiri Devlet Hastanesi   (Turkey)

Author keywords

Epithelial ovarian carcinoma; Interval debulking surgery; Interval laparotomy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; PLATINUM DERIVATIVE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; EPITHELIUM CELL; HUMAN; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FORECASTING; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOADJUVANT THERAPY; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 44349090866     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Huober J., Meyer A., Wagner U., Wallwiener D.: "The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer". J. Cancer Res. Clin. Oncol., 2002, 128, 153.
2. Chan J.K., Manuel M., Osann K., Cheung M.K.: "Progress and trends in ovarian cancer survival over the last 15 years". Abstract on Annual Meetings on Women's Cancer. Society of Gynecologic Oncology, 2005.
3. Skirnisdottir I., Sorbe B.: "Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-Stages III-IV) epithelial ovarian carcinoma". Int. J. Oncol., 2007, 30, 727.
4. Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Poynor E.A., Aghajanian C. et al.: "The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with Stages IIIC-IV epithelial ovarian cancer". Gynecol. Oncol., 2006, 103, 1083.
5. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., Podratz K.C., Cliby W.A.: "Aggressive surgical effort and improved survival in advanced-stage ovarian cancer". Obstet. Gynecol., 2006, 107, 77.
6. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., Montz F.J.: "Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis". J. Clin. Oncol., 2002, 20, 1248.
7. Hunter R.W., Alexander N.D., Soutter W.P.: "Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?". Am. J. Obstet. Gynecol., 1992, 166, 504.
8. Covens A.L.: "A critique of surgical cytoreduction in advanced ovarian cancer". Gynecol. Oncol., 2000, 78, 269.
9. Morice P., Brehier-Ollive D., Rey A., Atallah D., Lhomme C., Pautier P. et al.: "Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study". Ann. Oncol., 2003, 14, 74.
10. Vergote I., de Wever I., Tjalma W., Van Gramberen M., Decloedt J., Van Dam P.: "Interval debulking surgery: an alternative for primary surgical debulking?". Semin. Surg. Oncol., 2000, 19, 49.
11. Gallo A., Frigerio L.: "Neoadjuvant chemotherapy and surgical considerations in ovarian cancer". Curr. Opin. Obstet. Gynecol., 2003, 15, 25.
12. Pecorelli S., Odicino F., Favalli G.: "Interval debulking surgery in advanced epithelial ovarian cancer". Best. Pract. Res. Clin. Obstet. Gynaecol., 2002, 16, 573.
13. Schwartz P.E.: "Neoadjuvant chemotherapy for the management of ovarian cancer". Best. Pract. Res. Clin. Obstet. Gynaecol., 2002, 16, 585.
14. Redman C.W., Warwick J., Luesley D.M., Varma R., Lawton F.G., Blackledge G.R.: "Intervention debulking surgery in advanced epithelial ovarian cancer". Br. J. Obstet. Gynaecol., 1994, 101, 142.
15. van der Burg M.E., van Lent M., Buyse M., Kobierska A., Colombo N., Favalli G. et al.: "The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer". N. Engl. J. Med., 1995, 332, 629.
16. Kehoe S., Shafi M., Luesley D.: "Interval cytoreduction in ovarian cancer (letter)". N. Engl. J. Med., 1995, 333, 254.
17. Neijt J.P.: "Interval cytoreduction in ovarian cancer (letter)". N. Engl. J. Med., 1995, 333, 254.
18. Cannistra S.A.: "Interval cytoreduction in ovarian cancer (letter)". N. Engl. J. Med., 1995, 333, 255.